The Polyplastics Group is expanding its DURACON polyoxymethylene (POM) PM series portfolio with the development of a new high-flow grade for drug contact and delivery applications for the medical and healthcare market.

The new grade, DURACON PM27S01N, offers reduced wall thickness, miniaturization, and lower weight for various medical devices that are becoming increasingly complicated and highly functional.

Polyplastics’ PM series, which also includes DURACON PM09S01N, a standard viscosity grade, complements the company’s TOPAS cyclic olefin copolymer (COC) product, a high-purity material for a range of medical applications.

Polyplastics expands DURACON POM PM series with new high-flow grade for medical and healthcare industry.

DURACON PM27S01N delivers global medical and food regulatory compliance. It meets regulatory compliance requirements including ISO10993 and USP Class VI biocompatibility/cytotoxicity, FDA Drug Master File (DMF) and Device Master File (MAF), and EU 10/2011 and FDA food-contact 21 CFR 177.2470. 

The material adheres to strict quality management systems including conformity to VDI guideline, VDI 2017 medical-grade plastics. It also provides full traceability of processes and products, and production management based on GMP principle.

Polyplastics offers medical device manufacturers data on the long-term reliability of its materials. Customized data on extraction, moldability, durability, slip and wear, and other key attributes is also available. 

TOPAS COC is a glass-clear and highly pure plastic which offers stiffness and barrier resistance, biocompatibility, and drug compatibility for wearables, drug delivery, medical devices, pharmaceutical blisters and trays, and diagnostics and microfluidics.

The Polyplastics Group is expanding its DURACON polyoxymethylene (POM) PM series portfolio with the development of a new high-flow grade for drug contact and delivery applications for the medical and healthcare market.

The new grade, DURACON PM27S01N, offers reduced wall thickness, miniaturization, and lower weight for various medical devices that are becoming increasingly complicated and highly functional.

Polyplastics’ PM series, which also includes DURACON PM09S01N, a standard viscosity grade, complements the company’s TOPAS cyclic olefin copolymer (COC) product, a high-purity material for a range of medical applications.

Polyplastics expands DURACON POM PM series with new high-flow grade for medical and healthcare industry.

DURACON PM27S01N delivers global medical and food regulatory compliance. It meets regulatory compliance requirements including ISO10993 and USP Class VI biocompatibility/cytotoxicity, FDA Drug Master File (DMF) and Device Master File (MAF), and EU 10/2011 and FDA food-contact 21 CFR 177.2470. 

The material adheres to strict quality management systems including conformity to VDI guideline, VDI 2017 medical-grade plastics. It also provides full traceability of processes and products, and production management based on GMP principle.

Polyplastics offers medical device manufacturers data on the long-term reliability of its materials. Customized data on extraction, moldability, durability, slip and wear, and other key attributes is also available. 

TOPAS COC is a glass-clear and highly pure plastic which offers stiffness and barrier resistance, biocompatibility, and drug compatibility for wearables, drug delivery, medical devices, pharmaceutical blisters and trays, and diagnostics and microfluidics.